Caspofungin versus liposomal amphotericin B: are they really comparable?

Pediatr Infect Dis J. 2010 Oct;29(10):985-6; author reply 986-7. doi: 10.1097/INF.0b013e3181f2d878.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Amphotericin B / adverse effects
  • Amphotericin B / therapeutic use*
  • Antifungal Agents / therapeutic use*
  • Caspofungin
  • Echinocandins / adverse effects
  • Echinocandins / therapeutic use*
  • Fever of Unknown Origin / complications
  • Fever of Unknown Origin / drug therapy*
  • Humans
  • Immunocompromised Host
  • Lipopeptides
  • Neutropenia / complications
  • Neutropenia / drug therapy*
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Echinocandins
  • Lipopeptides
  • liposomal amphotericin B
  • Amphotericin B
  • Caspofungin